Ascend Wellness Holdings, Inc. (AAWH)

Name: Ascend Wellness Holdings, Inc. (AAWH) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001756390 · OTC · Medicinal Chemicals & Botanical Products

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Ascend Wellness Holdings, Inc. reported revenue of $500.58M. Revenue fell 10.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $488.33M.

Key ratios (year ended 2025-12-31)

33.9%

Gross margin

-3.4%

Operating margin

-23.6%

Net margin

-10.9%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-31

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Revenue	$488.33M	$500.58M	$561.60M	$518.59M	$405.93M	$332.38M	$143.73M	$12.03M
Cost of Revenue	$309.23M	$330.90M	$377.39M	$363.47M	$271.36M	$196.41M	$82.82M	$8.74M
Gross Profit	$179.10M	$169.68M	$184.21M	$155.12M	$134.56M	$135.97M	$60.91M	$3.29M
Operating Income	-$10.67M	-$17.01M	$4.73M	-$3.62M	-$7.53M	-$17.20M	$7.85M	-$26.12M
Depreciation & Amortization	$76.63M	$73.53M	$66.16M	$58.98M	$37.11M	$22.22M	$12.56M	$4.10M
EBITDA	$65.96M	$56.52M	$70.89M	$55.36M	$29.58M	$5.01M	$20.41M	-$22.02M
Net Income	-$113.83M	-$118.19M	-$84.99M	-$48.21M	-$80.90M	-$122.66M	-$23.84M	-$33.24M
EPS (Diluted)	n/a	-$0.58	-$0.40	-$0.24	-$0.44	-$0.82	-$0.27	-$0.37
Total Assets	$888.32M	$907.93M	$900.43M	$919.55M	$872.16M	$723.44M	$427.75M	n/a
Total Liabilities	$973.41M	$954.55M	$828.63M	$776.68M	$708.75M	$546.96M	$423.96M	n/a
Long-Term Debt	$334.36M	$319.52M	$308.02M	n/a	n/a	n/a	n/a	n/a
Shareholders' Equity	-$85.09M	-$46.62M	$71.80M	$142.87M	$163.41M	$176.48M	$3.79M	$34.84M
Cash & Equivalents	$67.00M	$85.68M	$88.25M	$72.51M	$74.15M	$155.48M	$56.55M	n/a
Operating Cash Flow	$17.35M	$38.05M	$73.29M	$75.33M	-$38.36M	-$41.74M	-$6.00M	-$40.93M
Capital Expenditures	$24.30M	$26.01M	$22.53M	$24.25M	$81.64M	$88.43M	$26.42M	$41.67M
Free Cash Flow	-$6.95M	$12.04M	$50.76M	$51.09M	-$120.00M	-$130.17M	-$32.42M	-$82.60M
Shares Outstanding	n/a	202.22M	205.03M	206.88M	188.06M	171.59M	n/a	n/a
Weighted Average Diluted Shares	n/a	203.48M	212.43M	199.15M	183.38M	149.43M	95.17M	n/a
EPS (Basic)	n/a	-$0.58	-$0.40	-$0.24	-$0.44	-$0.82	-$0.27	-$0.37